National Association of Benefits and Insurance Professionals
Based in DC
🤖
AI Overview
With $8.6M in lobbying spend across 28 quarterly filings, National Association of Benefits and Insurance Professionals is one of the biggest lobbying spenders in Washington. Their lobbying covers 6 issue areas. Active from 2018 to 2024.
$8.6M
Total Spend
7
Years Active
1
Firms Hired
6
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $1.3M |
| 2019 | $1.3M |
| 2020 | $1.3M |
| 2021 | $1.3M |
| 2022 | $1.6M |
| 2023 | $1.3M |
| 2024 | $332K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Taxation, Medicare/Medicaid, Health Issues, Pharmacy and 1 more
- •H.R. 5104 - A bill to amend title XVIII of the Social Security Act to provide for a special enrollment period under Medicare for individuals enrolled in COBRA continuation coverage, and for other purp
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
America's Health Insurance Plans INC (Ahip)
$96.4M total spend
F Hoffmann-la Roche LTD and its Affiliates
$4.0M total spend
Carefirst Bluecross Blueshield
$3.4M total spend
Biotechnology Industry Organization
$2.8M total spend
Blood Cancer United (Formerly Reported Asthe Leukemia and Lymphoma Society)
$1.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.